|
Patient
|
Glioma (G)/metastasis (M)
|
Prescribed dose [Gy]
|
Beam configuration
|
PTVvol [cc]
|
Bone resected (yes/no)
|
Max d* [mm]
|
Tumour location
|
|---|
|
1
|
M
|
25.0
|
2 arcs
|
31
|
N
|
–
|
Right thalamus
|
|
2
|
G
|
34.0
|
2 arcs, NC
|
408
|
Y
|
10
|
Right frontal/temporal
|
|
3
|
M
|
30.0
|
1 arc
|
5
|
Y
|
10
|
Left frontal
|
|
4
|
M
|
30.0
|
3 arcs, NC
|
10
|
Y**
|
10
|
Right occipital
|
|
5
|
G
|
40.05
|
1 arc
|
181
|
Y
|
10
|
Left frontal/parietal
|
|
6
|
G
|
40.05
|
2 arcs
|
448
|
Y
|
10
|
Right temporal
|
|
7
|
G
|
40.05
|
2 half arcs
|
186
|
Y
|
10
|
Left occipital/temporal
|
|
8***
|
M
|
30.0
|
2 arcs
|
21
|
Y
|
20
|
Cerebellum
|
|
9
|
M
|
30.0
|
1 arc
|
41
|
N
|
–
|
Right frontal
|
|
10***
|
M
|
30.0
|
2 arcs
|
2
|
N
|
–
|
Left occipital
|
|
11
|
G
|
60.0
|
4 arcs, NC
|
439
|
Y
|
10
|
Bilateral frontal/temporal
|
|
12
|
G
|
34.0
|
2 half arcs
|
314
|
Y
|
10
|
Left frontal/temporal
|
|
13
|
M
|
24.0
|
2 arcs
|
63
|
N
|
–
|
Left temporal
|
|
14
|
G
|
60.0
|
2 arcs
|
179
|
Y
|
10
|
Left frontal/temporal
|
|
15
|
G
|
60.0
|
2 half arcs
|
168
|
Y
|
10
|
Left temporal/occipital
|
|
16***
|
G
|
60.0
|
2 arcs, NC
|
430
|
Y
|
30
|
Left hemisphere
|
|
17
|
M
|
30.0
|
2 arcs
|
16
|
N
|
–
|
Left parietal
|
|
18
|
G
|
25.0
|
2 arcs
|
318
|
Y
|
10
|
Left hemisphere
|
|
19
|
M
|
30.0
|
2 arcs, NC
|
21
|
Y**
|
10
|
Right occipital
|
|
20
|
M
|
30.0
|
3 arcs, NC
|
25
|
N
|
-
|
Right parietal
|
- Patients identified as having targets in complex regions were number 2, 6, 8, 11, 14, 16 and 18
- *Max d refers to the maximum diameter of the bone resection. One patient may have more than one resection area, in which case the largest one is presented
- **Bone resection from previous surgery, not adjacent to the PTV evaluated in this study
- ***Three of the patients are presented in Fig. 1 to represent the range of tumour locations and sizes; patient 10 corresponds to patient A, patient 8 corresponds to patient B and patient 16 corresponds to patient C
